Senate Unanimously Passes Bill to Reduce Big Pharma Patent ...

The Senate on Thursday unanimously passed a bill aimed at limiting the number of patents drugmakers can introduce and making it easier for ...

Senate Unanimously Passes Bipartisan Pharma Patent Reform Bill

In July 2024, the Senate unanimously passed a bill that could help lower the costs of prescription drugs by allowing generic and biosimilar ...

Senate unanimously endorses legislation targeting pharma 'patent ...

The bill aims to fight “patent thicketing,” a tactic the branded drug industry uses to delay or thwart competition. Patent thicketing occurs ...

Senate Unanimously Passes Bill to Limit Patent Infringement ...

The APPA would revise certain provisions of 35 U.S.C. § 271(e) to limit the number of patents a drug manufacturer can assert in a patent ...

A Patent Thicket Bill Passed The Senate. There's More Work to Do.

Last month, the Senate unanimously passed the Affordable Prescriptions for Patients Act, a bill aimed at curbing patent abuse.

Senate Unanimously Passes Bill To Limit Patent Infringement ...

The APPA would revise certain provisions of 35 U.S.C. § 271(e) to limit the number of patents a drug manufacturer can assert in a patent ...

Bill that would cut down 'patent thickets' clears Senate

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs.

P4ADNow Applauds Senate Passage Of Bill To Curb Patent ...

WASHINGTON, D.C. — In a major step forward for patients and consumers, the U.S. Senate has unanimously passed the Affordable Prescriptions ...

Senate unanimously passes bipartisan pharma patent bill

The Senate in a unanimous vote Thursday afternoon passed a bill that aims to tackle pharmaceutical patent abuses by limiting the number of patents that

Arnold Ventures Commends Senate on Unanimous…

Statement from Mark E. Miller, Executive Vice President of Health Care at Arnold Ventures. WASHINGTON D.C. (Jul. 11, 2024)- “Reforms to patent law are ...

U.S. Senate Passes Affordable Prescriptions for Patients Act of 2023 ...

If enacted, the bill would limit the number of certain types of patents that the biologic innovator can assert against the biosimilar applicant ...

Senate Passes Legislation to Prevent Patent Thickets, Lower Drug ...

On July 11, the US Senate unanimously passed the Affordable Prescriptions for Patients Act. Sponsored by Senators John Cornyn (R-TX) and ...

150), a bipartisan measure led by Senator Cornyn (R-TX) and Senator Blumenthal (D-CT). This critical bill aims to reform rampant patent abuse in ...

Cornyn, Blumenthal Bill to Lower Drug Costs Passes Senate ...

By stopping abuses of our patent system, this legislation will pave the way for generics and biosimilars to compete with branded drugs and aggressively lower ...

Senate Unanimously Passes Bill to Reduce Big Pharma Patent ...

The Senate on Thursday unanimously passed a bill aimed at limiting the number of patents drugmakers can introduce and making it easier for generic and ...

ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. ...

In case you missed it, the U.S. Senate voted unanimously Thursday to pass an amended version of The Affordable Prescriptions for Patients Act (S ...

Senate Clears Patent Bill Aiming To Lower Drug Prices - Law360

The U.S. Senate on Thursday passed a bill that would pump the brakes on the ability of pharmaceutical companies to steer patients away from ...

S.3583 - A bill to address patent thickets. 118th Congress (2023-2024)

Text for S.3583 - 118th Congress (2023-2024): A bill to address patent thickets.

Senate Passes AARP-Backed Bill to Help Lower Drug Prices

The bill passed unanimously in the Senate without a roll call vote. It addresses a tactic known as patent thicketing, where drug companies ...

This Week in Drug Pricing: Bipartisan Patent Thicket Legislation ...

This Week in Drug Pricing: Bipartisan Patent Thicket Legislation Unanimously Clears The Senate, FTC's Scathing Report On PBMs, Fact V. Pharma ...